[ad_1] Second Quarter 2024 Net income of $78.9 million, or $0.49 per GAAP diluted share Net sales of $1.5 billion Combined adjusted EBITDA of $273.6 million Repurchased $29.2 million of common stock Received $77.1 million […]
Trending Stories
Dow reviews 2nd quarter 2024 effects
[ad_1] MIDLAND, Mich., July 25, 2024 /PRNewswire/ — Dow (NYSE: DOW): FINANCIAL HIGHLIGHTS GAAP profits consistent with percentage was once $0.62; working profits consistent with percentage (EPS)1 was once $0.68, in comparison to $0.75 within […]
HONEYWELL DELIVERS STRONG SECOND QUARTER RESULTS AND BEATS EARNINGS GUIDANCE; UPDATES 2024 OUTLOOK
[ad_1] Sales of $9.6 Billion, Reported Sales Up 5%, Organic1 Sales Up 4%, Achieving the High End of Previous Guidance Earnings Per Share of $2.36 and Adjusted Earnings Per Share1 of $2.49, Above High End […]
Thailand First Part Funding Packages Stand 35% to US$ 12.8 billion on a Surge in Tasks in Key Sectors; E&E Once more Tops Sectors Record
[ad_1] BANGKOK, July 25, 2024 /PRNewswire/ — The Thailand Board of Funding (BOI) stated as of late that programs for funding promotion all over January to June 2024 higher 35% on moment in price to […]
IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication — Systemic Lupus Erythematosus (SLE)
[ad_1] SHANGHAI, NANJING, China and SAN JOSE, Calif. , July 25, 2024 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, hereby announces […]
